Wolfgang W Leitner
Overview
Explore the profile of Wolfgang W Leitner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1023
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joffe A, Vazquez-Maldonado N, Singleton K, Leitner W
Trends Pharmacol Sci
. 2024 Nov;
45(12):1097-1099.
PMID: 39521663
Screening small molecule (SM) libraries now replaces traditional methods for vaccine adjuvant discovery. A study by Soni et al. highlights the use of primary human cells in high-throughput screening (HTS),...
2.
Dang Q, Eichelberg K, Vazquez-Maldonado N, Boggiano C, Leitner W, Ramachandra L, et al.
Front Immunol
. 2024 Oct;
15:1429250.
PMID: 39439805
No abstract available.
3.
Singh A, Boggiano C, Yin D, Polakowski L, Majji S, Leitner W, et al.
Sci Transl Med
. 2024 Sep;
16(763):eabq7378.
PMID: 39231242
Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in pediatric vaccine design. A better understanding of...
4.
Sei S, Srivastava S, Kelly H, Miller M, Leitner W, Shoemaker R, et al.
Cancer Immunol Res
. 2024 Apr;
12(4):387-392.
PMID: 38562082
Cancer prevention and early detection, the first two of the eight primary goals of the National Cancer Plan released in April 2023, are at the forefront of the nation's strategic...
5.
Vazquez-Maldonado N, Kelly H, Leitner W
Hum Vaccin Immunother
. 2023 Jun;
19(2):2223503.
PMID: 37341528
Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human...
6.
Singh A, Boggiano C, Eller M, Maciel Jr M, Marovich M, Mehra V, et al.
Vaccine
. 2023 Jun;
41(31):4439-4446.
PMID: 37331838
This report summarizes the highlights of a workshop convened by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on April 4-5, 2022, to provide...
7.
Knisely J, Buyon L, Mandt R, Farkas R, Balasingam S, Bok K, et al.
NPJ Vaccines
. 2023 Apr;
8(1):53.
PMID: 37045860
No abstract available.
8.
Singleton K, Joffe A, Leitner W
Front Immunol
. 2023 Feb;
14:1105655.
PMID: 36742311
Vaccine adjuvant research is being fueled and driven by progress in the field of innate immunity that has significantly advanced in the past two decades with the discovery of countless...
9.
Andrisani O, Liu Q, Kehn P, Leitner W, Moon K, Vazquez-Maldonado N, et al.
Nat Immunol
. 2022 Feb;
23(3):354-357.
PMID: 35194205
No abstract available.
10.
Prasanna P, Woloschak G, DiCarlo A, Buchsbaum J, Schaue D, Chakravarti A, et al.
Radiat Res
. 2020 Oct;
194(5):452-464.
PMID: 33045077
The limited impact of treatments for COVID-19 has stimulated several phase 1 clinical trials of whole-lung low-dose radiation therapy (LDRT; 0.3-1.5 Gy) that are now progressing to phase 2 randomized...